Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stage I Prostate Adenocarcinoma AJCC v7 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1

Interventions

Magnetic Resonance Spectroscopy 56 enzalutamide 44 Specimen Handling 37 apalutamide 35 Androgen Antagonists 35 Abiraterone Acetate 29 Prednisone 27 Radiosurgery 26 darolutamide 25 Docetaxel 23 Pluvicto 22 abiraterone 21 Radiotherapy 21 Leuprolide 20 Biopsy 16 relugolix 14 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 14 gallium 68 PSMA-11 12 Triptorelin Pamoate 12 Surveys and Questionnaires 12 Radiation 12 Gonadotropin-Releasing Hormone 12 X-Rays 11 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 10 cabazitaxel 9 bicalutamide 9 Standard of Care 9 Nivolumab 9 Goserelin 9 Carboplatin 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × nilutamide × 90 days × Clear all

NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡